KDR and neoplasm: Furthermore, it has been recently described that glutaminolysis drives tumor angiogenesis by controlling endothelial growth factor receptor 2 (VEGFR2) and fibroblast growth factor receptor 1(FGFR1) translation via mTORC1 activation [71] (Figure 1C).